Grupo de investigación de biomarcadores en cáncer (GReBiC)
- Número de publicaciones
- 465
Publicaciones
-
Rodríguez, JV; Prieto, A; Vilaprinyo, E; Bonet, M; Diez, M; Salud, A; Montal, R
Surrogate endpoints in phase III randomized trials of advanced gastroesophageal cancer: A systematic review and meta-analysis
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 201 -. .
-
Sundaralingam A; Grabczak EM; Burra P; Costa MI; George V; Harriss E; Jankowska E; Janssen JP; Karpathiou G; Laursen CB; Maceviciute K; Maskell N; Mei F; Nagavci B; Panou V; Pinelli V; Porcel JM; Ricciardi S; Shojaee S; Welch H; Zanetto A; Udayaraj UP; Cardillo G; Rahman NM
ERS Statement on Benign Pleural Effusions in Adults.
EUROPEAN RESPIRATORY JOURNAL -. .
-
Wang, YF; Yang, Q; Hai, L; Zhou, F; Zhang, L; Wang, YJ; Gao, WH; Yan, L; Jiang, TW; Huang, JH; Chen, H; Zhou, QH; Porcel, JM; Zheng, WQ; Hu, ZD
Pleural pro-gastrin releasing peptide is a potential diagnostic marker for malignant pleural effusion induced by small-cell lung cancer
Journal of Thoracic Disease 16 4440-4446. .
-
Piazzolla M; De Pace CC; Porcel JM; Tondo P
Local Anesthetic Thoracoscopy: A Focus on Indications, Techniques and Complications.
ARCHIVOS DE BRONCONEUMOLOGIA 60 423-430. .
-
Porcel, JM; Pont, M; Sorolla, A
CRISPR Technology in Lung Diseases: The Example of Lung Cancer and Cystic Fibrosis
ARCHIVOS DE BRONCONEUMOLOGIA 60 397-399. .
-
Porcel JM
Pleural mesothelioma: surgery questioned again?
EUROPEAN RESPIRATORY JOURNAL 63 -. .
-
Porcel JM; Lee YCG
Advances in pleural diseases.
EUROPEAN RESPIRATORY JOURNAL 63 -. .
-
Nguyen NP; Chirila ME; Page BR; Vinh-Hung V; Gorobets O; Mohammadianpanah M; Giap H; Arenas M; Bonet M; Lara PC; Kim L; Dutheil F; Lehrman D; Montes LZ; Tlili G; Dahbi Z; Loganadane G; Blanco SC; Bose S; Natoli E; Li E; Mallum A; Morganti AG
Immunotherapy and stereotactic body radiotherapy for older patients with non-metastatic renal cancer unfit for surgery or decline nephrectomy: practical proposal by the International Geriatric Radiotherapy Group.
Frontiers in oncology 14 1391464-1391464. .
-
Valladares-Ayerbes, M; Safont, MJ; Flores, EG; García-Alfonso, P; Aranda, E; Muñoz, AML; Ferrer, EF; Nogueras, LC; Rodríguez-Salas, N; Aparicio, J; Muñoz, ML; Cáceres, PPP; Trujillo, OAC; Tocino, RV; Fernández, MS; Salud-Salvia, A; Sureda, BM; Garcia-Carbonero, R; Conesa, MAV; Vila, AL
Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study
CLINICAL & TRANSLATIONAL ONCOLOGY -. .
-
Freyer, G; Martinez-Jañez, N; Kukielka-Budny, B; Ulanska, M; Bourgeois, H; Muñoz, M; Morales, S; Calero, JB; Cortesi, L; Pintér, T; Palácová, M; Cherciu, N; Petru, E; Ettl, J; de Almeida, C; Villanova, G; Raymond, R; Minh, CTT; Rodrigues, A; Cazzaniga, ME
Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study
BREAST 74 103681-103681. .
-
Martinez-Jañez, N; Ezquerra, MB; Sanchez, LMM; Carrasco, FH; Torres, AA; Morales, S; Ortega, PT; Gil, VLO; Sampedro, T; Conejero, RA; Calvo-Martinez, L; Galve-Calvo, E; López, R; de la Pena, FA; Lopez-Tarruella, S; de Araguiz, BAHF; Ruiz, LB; Cardenas, TM; Chacon, JI; Antón, FM
First-line therapy with palbociclib in patients with advanced HR+/HER2- breast cancer: The real-life study PALBOSPAIN
BREAST CANCER RESEARCH AND TREATMENT 206 57-65. .
-
García-Díaz HC; Eremiev S; Gómez-Alonso J; Veas Rodriguez J; Farriols A; Carreras MJ; Serrano C
Hyperammonemic encephalopathy after tyrosine kinase inhibitors: A literature review and a case example.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE 30 576-583. .
